Subhashini Srinivasan

Title: Subhashini Srinivasan: Innovator in Cytokine Research

Introduction

Subhashini Srinivasan is a notable inventor based in Kirkland, WA (US). She has made significant contributions to the field of biotechnology, particularly in the area of cytokine research. With a total of 10 patents to her name, her work has had a profound impact on the development of therapeutic applications.

Latest Patents

Among her latest patents is the invention related to DNA encoding CD40 ligand, a cytokine that binds CD40. This invention discloses a polypeptide (CD40-L) along with DNA sequences, vectors, and transformed host cells that are useful in providing CD40-L polypeptides. More specifically, it provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor. Another significant patent involves the use of CD40 ligand to stimulate hybridoma cells. This invention also discloses a polypeptide (CD40-L) and methods for increasing monoclonal antibody production by administering a CD40 ligand polypeptide that stimulates B cell proliferation.

Career Highlights

Throughout her career, Subhashini has worked with prominent organizations, including Immunex Corporation. Her innovative research has positioned her as a key figure in the biotechnology sector, contributing to advancements in immunology and therapeutic development.

Collaborations

Subhashini has collaborated with notable colleagues such as Melanie K Spriggs and Richard Jeffrey Armitage. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Subhashini Srinivasan's contributions to cytokine research and her impressive portfolio of patents underscore her role as a leading innovator in biotechnology. Her work continues to influence the field and pave the way for future advancements.